在耐药性壮症中对骨共患病的新方法
Stefano Frara1,2, Matteo Acanfora3,4, Vincenzo Franzese3,4
1Institute of Endocrine and Metabolic Sciences, Università Vita-Salute San Raffaele, Via Olgettina, 58, Milan, 20132, Italy. frara.stefano@hsr.it.
Pituitary
|November 21, 2024
概括
活跃的壮症会导致骨脆弱和骨折,影响生活质量. 关键是骨质量,而不是骨密度,这凸显了疾病控制和骨健康的潜在疗法的需要.
科学领域:
- 内分泌学 在内分泌学.
- 骨的新陈代谢 骨的新陈代谢
- 类风湿病学 类风湿病学
背景情况:
- 活跃的壮症与显著的骨并发症有关,包括骨质病和骨折.
- 这些骨折与疾病持续时间和生长激素 (GH) 水平升高有关,对患者的生活质量产生负面影响.
- 与原发性骨质疏松症不同,骨矿物质密度对于骨折风险评估来说是不可靠的;骨质质量受到损害.
研究的目的:
- 审查现有和新出现的关于活跃和耐性壮症患者骨脆弱性的证据.
- 突出骨质质量评估 (例如,状骨评分) 与骨矿物质密度相比的重要性.
- 讨论骨折预防策略,重点是疾病控制和维生素D和沙雷胺的潜在治疗作用.
主要方法:
- 对调查壮症骨并发症的研究进行文献综述.
- 分析用于评估骨微观结构的计算机断层扫描 (CT) 技术.
- 综合证据关于骨折风险因素和壮症的管理.
主要成果:
- 患有活跃壮症的患者表现出骨质受损,其证据是低椎骨分数 (TBS) 和受损的微型架构 (椎骨和皮质骨).
- 观察到高频率的脊椎骨折 (高达40-50%),与疾病持续时间和GH水平有关.
- 骨矿物质密度通常是正常的或仅略有降低,使其成为骨折风险的不良预测指标.
结论:
- 骨脆弱性是活跃壮症的一个主要问题,由骨质差而不是骨密度低驱动.
- 疾病控制对预防骨折至关重要,尽管维生素D和沙里胺可以提供独立的保护性益处.
- 需要对骨活性药物进行进一步的研究,但目前的管理应该专注于控制GH过量和解决骨质缺陷.
关键词:
壮成长是一种壮成长.GH GH GH GH 的意思是什么?国际分支基金 (IGF-I) 的第一部分.骨质疏松症是一种骨质疏松症.帕西雷奥提德是什么类型的佩格维索曼特是什么意思在SRL中,它是SRL.脊椎骨折是指脊椎骨折的发生.更多相关视频
05:55Author Spotlight: Developing a Rat Model for Weight-Bearing Intervention to Investigate Osteonecrosis of the Femoral Head
Published on: September 27, 2024
472
04:19Minimally Invasive Treatment for Thoracolumbar Burst Fracture Using Sagittal Alignment Screws and A Trauma Reduction Device
Published on: November 8, 2024
358
相关概念视频
01:29Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K
01:17Hormones and Bone Tissue
2.6K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.6K
01:31Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K